Silencing the speech gene FOXP2 causes breast cancer cells to metastasize

2014-10-22

(Press-News.org) BOSTON – It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other parts of the body, a process known as metastasis.

Now a research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has identified an unexpected link between a transcription factor known to regulate speech and language development and metastatic colonization of breast cancer.

Currently described online in Cell Stem Cell, the new findings demonstrate that, when silenced, the FOXP2 transcription factor, otherwise known as the speech gene, endows breast cancer cells with a number of malignant traits and properties that enable them to survive – and thrive.

"We have identified a previously undescribed function for the transcription factor FOXP2 in breast cancer," explains senior author Antoine Karnoub, PhD, an investigator in the Department of Pathology at BIDMC and Assistant Professor of Pathology at Harvard Medical School. "We have found that depressed FOXP2 [a member of the forkhead family of transcriptional regulators] and elevated levels of its upstream inhibitor microRNA 199a are prominent features of clinically advanced breast cancers that associate with poor patient survival."

Karnoub's lab investigates the roles that mesenchymal stem cells (MSCs) play in the development and metastasis of breast cancer. MSCs are adult progenitor cells that function as the body's early responders, poised to take action to help repair damaged tissues, jumping from their niches in the bone, for example, into the blood, migrating to areas of inflammation, and orchestrating the body's reactions during wound healing. Previous work by Karnoub revealed that MSCs respond to breast tumors akin to the way they react to a wound or infection and that these cells participate in the formation of the breast tumor stroma, the supporting network of cells and their secretions that exist in the microenvironment of cancer cells.

"We think that by direct actions on the cancer cells and by manipulating other cells in the microenvironment, MSCs end up providing cancer cells with better abilities to survive and a safe haven in which to thrive," says Karnoub. Despite expanding knowledge of the role of MSCs to breast malignancy, the underlying molecular responses of breast cancer cells to MSC influences has not been fully delineated. In this new paper, the investigators set out to specifically identify the role that microRNAs were playing in the process.

miRNAs are short noncoding RNAs that play critical functions in cancer pathogenesis,. "An expanding body of evidence has documented miRNA deregulation in multiple aspects of tumor development, including invasion and metastasis," says Karnoub. The induction by MSCs of one such miRNA, miR199a, facilitated the acquisition of malignant properties by the cancer cells, including cancer stem cell and metastatic traits. (Cancer stem cells are thought to be the most virulent cells that lie within the core of most tumors, and are believed to be responsible for the resurgence of tumors following chemotherapy treatment.)

"After we found that miRNA-199a instigated in the cancer cells by MSCs was indeed promoting these cancer stem cells phenotypes and was facilitating cancer metastasis, we probed the mechanistic details of miR-199a's actions, " explains Karnoub. "miRNAs function predominantly by suppressing target mRNA expression, and we analyzed an overwhelming majority of the published targets that have been associated with these miRNAs, but none was repressed in our systems. We then made a screen and serendipitously fished out a gene called FOXP2." At that time, he adds, basically nothing was known about this protein in relation to breast cancer.

FOXP2 has primarily been implicated in regulating speech and language development and several reports have described functions for this protein in developmental neurogenesis. Additional reports have also linked FOXP2 to tissue development, such as the lung.

"We were curious and wanted to find out the business of FOXP2 in breast cancer," he adds. "Surprisingly, we found that its suppression in the tumor cells was sufficient to expand cancer stem cell traits and caused the cancer cells to metastasize much more vigorously."

These findings agreed with similar results in which the authors determined that miR-199a upregulation and FOXP2 repression are prominent features of aggressive clinical breast cancers and represent independent prognostic parameters for overall patient survival.

"We are one step closer to understanding how cells in the tumor microenvironment, such as MSCs, promote the malignancy of neighboring cancer cells," says Karnoub. "We're now more closely investigating FOXP2's potential role as a metastasis suppressor that needs to be downregulated for metastasis to take place."

INFORMATION:

Study coauthors include BIDMC investigators Benjamin G. Cuiffo (first author), Antoine Campagne, Evan C. Lien and Manoj K. Bhasin; as well as George W. Bell, Antonio Lembo, Francesca Orso, , Monica Raimo, Summer E. Hanson, Andriy Marusyk, Dorraya El-Ashry, Peiman Hematti, Kornelia Polyak, Fatima Mechta-Grigoriou, Odette Mariani, Stefano Volinia, Anne Vincent-Salomon,and Daniela Taverna.

Coauthors are associated with Institut Curie, France; Whitehead Institute for Biomedical Research; University of Turin and MBC, University of Wisconsin-Madison School of Medicine and Public Health, Dana-Farber Cancer Institute, University of Miami Miller School of Medicine, and University of Ferrara, Italy.

This work was supported, in part, by the Sidney Kimmel Cancer Research Foundation, the Susan G. Komen For The Cure, the American Cancer Society, Compagnia di San Paolo, and Progetto Ricerca Ateneo Torino.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.

ELSE PRESS RELEASES FROM THIS DATE:

Study finds no increase in pregnancy-related death for African-American women

2014-10-22

October 22, 2014 – In contrast to national trends, a study performed at Alabama's largest hospital finds no racial difference in the risk of pregnancy-related death between African American and Caucasian women, reports the November issue of Anesthesia & Analgesia. However, the results show a significant increase in maternal mortality for women who live greater distances from the hospital, according to the study Dr Michael Froelich of University of Alabama at Birmingham (UAB) and colleagues. The findings point to differences in health care access as a possible explanation ...

Clinical trial could change standard treatment for stroke

2014-10-22

A large international clinical trial has shed new light on the effectiveness of current hospital protocols for managing blood pressure in stroke patients. The two-part ENOS trial (Efficacy of Nitric Oxide in Stroke,) was carried out at The University of Nottingham in collaboration with 23 countries to try to solve two major conundrums faced by doctors when treating people who have suffered a stroke — should blood pressure be lowered using medicated skin patches, and should existing blood pressure medication be stopped or continued after a stroke? The results of ...

Association between air toxics and childhood autism

2014-10-22

PITTSBURGH, Oct. 22, 2014 – Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania. This research, funded by The Heinz Endowments, will be presented today at the American Association for Aerosol Research annual meeting in Orlando, Fla. ...

Aphthous ulcers: Causes of mucosal inflammation are unclear

2014-10-22

A painful inflamed lesion on the oral mucosa, which often seems to be burning at the periphery: every third individual has at one point had such a lesion—an aphthous ulcer. Often they resolve after a brief period of time. In 2% to 10% of patients these lesions are recurrent and require medical treatment. Unfortunately, as Andreas Altenberg and co-authors point out in a current review on the therapy of aphthous ulcers (Dtsch Arztebl Int 2014; 111: 665–73), the etiology of these lesions is unclear. Thus aphthous ulcers can only be treated symptomatically. Even ...

Sopping up proteins with thermosponges

2014-10-22

Boston, MA – A research team led by Brigham and Women's Hospital (BWH) has developed and tested a novel nanoparticle platform that efficiently delivers clinically important proteins in vivo in initial proof-of-concept tests. Nanoparticles, which are particles measuring nanometers in size, hold promise for a range of applications, including human therapeutics. The key advantage of the new platform, known as a thermosponge nanoparticle, is that it eliminates the need for harsh solvents, which can damage the very molecules the particles are designed to carry. The study ...

BJOG releases MPT special supplement

2014-10-22

(Sacramento, CA): Broad-spectrum prevention that can simultaneously prevent unintended pregnancy along with STIs, including HIV, is on the horizon say experts in a special supplement of the BJOG: An International Journal of Obstetrics and Gynaecology. The issue features an international assemblage of researchers, funders, developers and advocates who identify the pressing global health rationale for MPTs and present new research and strategies for making the go/no-go funding and research decisions that shape the field. The invited guest editor for the supplement is Dr. ...

The 2011 English summer riots: Courts accused of 'collective hysteria'

2014-10-22

A review of sentencing following the 2011 English riots has shown that sentences were much harsher than realised at first. And just as people got caught up in the riots and acted out of character the study, carried out by The University of Manchester and Liverpool John Moores University, found that the courts themselves got caught up in a similar kind of collective hysteria. Dr Hannah Quirk, a Senior Lecturer in Criminal Law and Justice from The University of Manchester, was the co-author of the research which has just been published in The British Journal of Criminology. ...

Protecting us from our cells

2014-10-22

Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes or multiple sclerosis. A molecule called insulin-like growth factor-1 (IGF-1) boosts the body's natural defence against this 'friendly fire', scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have found. The findings, published today in EMBO Molecular Medicine, are especially exciting because IGF-1 is already approved for use in patients, ...

New window on the early universe

2014-10-22

Using two world-class supercomputers, the researchers were able to demonstrate the effectiveness of their approach by simulating the formation of a massive galaxy at the dawn of cosmic time. The ALMA radio telescope – which stands at an elevation of 5,000 meters in the Atacama Desert of Chile, one of the driest places on earth – was then used to forge observations of the galaxy, showing how their method improves upon previous efforts. It is extremely difficult to gather information about galaxies at the edge of the Universe: the signals from these heavenly ...

Proper dental care linked to reduced risk of respiratory infections in ICU patients

2014-10-22

CHICAGO (October 22, 2014) – New research shows vulnerable patients in the Intensive Care Unit (ICU) who received enhanced oral care from a dentist were at significantly less risk for developing a lower respiratory tract infection (LRTI), like ventilator-associated pneumonia, during their stay. The study was published in the November issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA). "Bacteria causing healthcare-associated infections often start in the oral cavity," said Fernando Bellissimo-Rodrigues, ...

LAST 30 PRESS RELEASES:

ASTRO issues update to clinical guideline on radiation therapy for rectal cancer

Mount Sinai opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to transform health care by spearheading the AI revolution